The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Natural Killer Cells Are Polarized Toward Cytotoxicity in Chronic Hepatitis C in an Interferon-Alfa–Dependent Manner
Open accessAbstract
Background and Aims: Patients with chronic hepatitis C virus (HCV) infection display great variability in disease activity and progression. While virus-specific adaptive immune responses have been extensively characterized and found to be impaired in chronic hepatitis C, the role of innate immune responses in disease activity and progression of chronic hepatitis C is not well understood. Methods and Results: Studying 42 HCV-infected patients and 12 healthy uninfected controls, we found an increased frequency of NK cells expressing TRAIL, NKp44, NKG2C and CD122 in chronic hepatitis C as compared to healthy controls (p<0.05 for all markers) and stronger activation of NK cells in the liver than in the blood (p<0.05). This NK cell phenotype was associated with polarization of NK cell function towards CD107a expression as a marker of degranulation, but with not increased interferon (IFN)-γ-production of CD56dim NK cells. The polarized NK cell phenotype correlated with alanine aminotransferase levels (r2=0.312, p=0.03). To investigate whether in vivo exposure of NK cells to HCV-induced type I IFN was causing this NK cell phenotype, peripheral blood mononuclear cells from 10 healthy controls and 8 HCV-infected patients were stimulated in the presence of IFN-α, which resulted in increased NK cell expression of TRAIL and CD107a (p<0.001), but not IFN-γ. Conclusions: Collectively, these results describe a polarized NK cell phenotype induced by chronic exposure to HCV-induced IFN-α. This phenotype may contribute to liver injury through TRAIL expression and cytotoxicity whereas the lacking increase in IFN-γ production may facilitate the inability to clear HCV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines
Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P., & Salazar-Mather, T. P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.189 · Cited by 2,113
Immunology of hepatitis B virus and hepatitis C virus infection
Rehermann, B., & Nascimbeni, M. (2005) · Nature Reviews Immunology · doi:10.1038/nri1573 · Cited by 1,627
Self-citationCD107a as a functional marker for the identification of natural killer cell activity
Alter, G., Malenfant, J. M., & Altfeld, M. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.08.008 · Cited by 1,410
Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus
Lechner, F., Wong, D. K. H., Dunbar, P. R., Chapman, R., Chung, R. T., Dohrenwend, P., Robbins, G., Phillips, R., Klenerman, P., & Walker, B. D. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.9.1499 · Cited by 1,269
HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
Khakoo, S. I., Thio, C. L., Martin, M. P., Brooks, C. R., Gao, X., Astemborski, J., Cheng, J., Goedert, J. J., Vlahov, D., Hilgartner, M., et al. (2004) · Science · doi:10.1126/science.1097670 · Cited by 1,179
Genomic analysis of the host response to hepatitis C virus infection
Su, A. I., Pezacki, J. P., Wodicka, L., Brideau, A. D., Supekova, L., Thimme, R., Wieland, S., Bukh, J., Purcell, R. H., Schultz, P. G., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202608199 · Cited by 1,161
Fehniger, T. A., Shah, M. H., Turner, M. J., VanDeusen, J. B., Whitman, S. P., Cooper, M. A., Suzuki, K., Wechser, M., Goodsaid, F., & Caligiuri, M. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.4511 · Cited by 652
Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease
Thimme, R., Bukh, J., Spangenberg, H. C., Wieland, S., Pemberton, J., Steiger, C., Govindarajan, S., Purcell, R. H., & Chisari, F. V. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202608299 · Cited by 639
Wedemeyer, H., He, X.-S., Nascimbeni, M., Davis, A. R., Greenberg, H. B., Hoofnagle, J. H., Liang, T. J., Alter, H., & Rehermann, B. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3447 · Cited by 634
Self-citationRadziewicz, H., Ibegbu, C. C., Fernandez, M. L., Workowski, K. A., Obideen, K., Wehbi, M., Hanson, H. L., Steinberg, J. P., Masopust, D., Wherry, E. J., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02021-06 · Cited by 483
Crotta, S., Stilla, A., Wack, A., D'Andrea, A., Nuti, S., D'Oro, U., Mosca, M., Filliponi, F., Brunetto, R. M., Bonino, F., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011124 · Cited by 471
Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions
Tseng, C.-T. K., & Klimpel, G. R. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011145 · Cited by 447
DNA Microarray Analysis of Chimpanzee Liver during Acute Resolving Hepatitis C Virus Infection
Bigger, C. B., Brasky, K. M., & Lanford, R. E. (2001) · Journal of Virology · doi:10.1128/jvi.75.15.7059-7066.2001 · Cited by 442
Dunn, C., Brunetto, M., Reynolds, G., Christophides, T., Kennedy, P. T., Lampertico, P., Das, A., Lopes, A. R., Borrow, P., Williams, K., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061287 · Cited by 421
Oliviero, B., Varchetta, S., Paudice, E., Michelone, G., Zaramella, M., Mavilio, D., De Filippi, F., Bruno, S., & Mondelli, M. U. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.05.047 · Cited by 412
Resident human hepatitis lymphocytes are phenotypically different from circulating lymphocytes
Norris, S., Collins, C., Doherty, D. G., Smith, F., McEntee, G., Traynor, O., Nolan, N., Hegarty, J., & O'Farrelly, C. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80206-7 · Cited by 374
Differential Cd4+ and Cd8+ T–Cell Responsiveness in Hepatitis C Virus Infection
Chang, K.-M., Thimme, R., Melpolder, J. J., Oldach, D., Pemberton, J., Moorhead-Loudis, J., McHutchison, J. G., Alter, H. J., & Chisari, F. V. (2001) · Hepatology · doi:10.1053/jhep.2001.21162 · Cited by 336
Lauer, G. M., Barnes, E., Lucas, M., Timm, J., Ouchi, K., Kim, A. Y., Day, C. L., Robbins, G. K., Casson, D. R., Reiser, M., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.06.015 · Cited by 303
Human natural killer cells: their origin, receptors and function
Moretta, L., Bottino, C., Pende, D., Mingari, M. C., Biassoni, R., & Moretta, A. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200205)32:5<1205::aid-immu1205>3.0.co;2-y · Cited by 266
Feld, J. J., Nanda, S., Huang, Y., Chen, W., Cam, M., Pusek, S. N., Schweigler, L. M., Theodore, D., Zacks, S. L., Liang, J. T., et al. (2007) · Hepatology · doi:10.1002/hep.21853 · Cited by 265
Self-citationTo kill or to cure: options in host defense against viral infection
Guidotti, L. G., & Chisari, F. V. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80034-3 · Cited by 264
Nattermann, J., Feldmann, G., Ahlenstiel, G., Langhans, B., Sauerbruch, T., & Spengler, U. (2006) · Gut · doi:10.1136/gut.2005.076463 · Cited by 236
Self-citationDe Maria, A., Fogli, M., Mazza, S., Basso, M., Picciotto, A., Costa, P., Congia, S., Mingari, M. C., & Moretta, L. (2007) · European Journal of Immunology · doi:10.1002/eji.200635989 · Cited by 220
Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection
Shin, E.-C., Seifert, U., Kato, T., Rice, C. M., Feinstone, S. M., Kloetzel, P.-M., & Rehermann, B. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29832 · Cited by 185
Self-citationDecreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing
Morishima, C., Paschal, D. M., Wang, C. C., Yoshihara, C. S., Wood, B. L., Yeo, A. E. T., Emerson, S. S., Shuhart, M. C., & Gretch, D. R. (2006) · Hepatology · doi:10.1002/hep.21073 · Cited by 174
Miyagi, T., Gil, M. P., Wang, X., Louten, J., Chu, W.-M., & Biron, C. A. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070401 · Cited by 174
Meier, U.-C., Owen, R. E., Taylor, E., Worth, A., Naoumov, N., Willberg, C., Tang, K., Newton, P., Pellegrino, P., Williams, I., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.19.12365-12374.2005 · Cited by 174
NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN‐γ secretion
Morandi, B., Bougras, G., Muller, W. A., Ferlazzo, G., & Münz, C. (2006) · European Journal of Immunology · doi:10.1002/eji.200636290 · Cited by 164
Ahlenstiel, G., Martin, M. P., Gao, X., Carrington, M., & Rehermann, B. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32400 · Cited by 161
Self-citationGolden‐Mason, L., Madrigal-Estebas, L., McGrath, E., Conroy, M. J., Ryan, E. J., Hegarty, J. E., O’Farrelly, C., & Doherty, D. G. (2008) · Gut · doi:10.1136/gut.2007.130963 · Cited by 159
Rutebemberwa, A., Ray, S. C., Astemborski, J. A., Levine, J., Liu, L., Dowd, K. A., Clute, S. C., Wang, C., Korman, A. J., Sette, A., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8215 · Cited by 150
Heterologous T cell immunity in severe hepatitis C virus infection
Urbani, S., Amadei, B., Fisicaro, P., Pilli, M., Missale, G., Bertoletti, A., & Ferrari, C. I. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041058 · Cited by 138
McIntyre, K. W., & Welsh, R. M. (1986) · The Journal of Experimental Medicine · doi:10.1084/jem.164.5.1667 · Cited by 108
Patzwahl, R., Meier, V., Ramadori, G. P., & Mihm, S. (2001) · Journal of Virology · doi:10.1128/jvi.75.3.1332-1338.2001 · Cited by 103
Sáez‐Borderías, A., Romo, N., Magri, G., Gumá, M., Angulo, A., & López‐Botet, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.2.829 · Cited by 102
Mundt, B., Wirth, T., Zender, L., Waltemathe, M., Trautwein, C., Manns, M. P., Kühnel, F., & Kubicka, S. (2005) · Gut · doi:10.1136/gut.2004.056929 · Cited by 100
IFNα regulates NK cell cytotoxicity through STAT1 pathway
Liang, S., Wei, H., Sun, R., & Zhigang, T. (2003) · Cytokine · doi:10.1016/s1043-4666(03)00226-6 · Cited by 85
Lin, L., Gorke, S., Rau, S. J., Zeisel, M. B., Hildt, E., Himmelsbach, K., Carvajal-Yepes, M., Huber, R., Wakita, T., Schmitt-Graeff, A. H., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4926 · Cited by 69
Natural killer cells suppress full cycle HCV infection of human hepatocytes
Wang, S. ‐., Huang, C. ‐., Ye, L., Wang, X., Li, S., Wang, Y. ‐., Liang, H., Huang, X. ‐., & Ho, W. Z. (2008) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2008.01014.x · Cited by 60
Larkin, J. D., Bost, A. G., Glass, J. I., & Tan, S. (2006) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2006.26.854 · Cited by 34
Innate Immunity and Viral Infections
Biron, C. A., Dalod, M., & Salazar‐Mather, T. P. (2014) · ASM Press eBooks · doi:10.1128/9781555817978.ch11 · Cited by 25
Cited by
Benci, J. L., Johnson, L. R., Choa, R., Xu, Y., Qiu, J., Zhou, Z., Xu, B., Ye, D., Nathanson, K. L., June, C. H., et al. (2019) · Cell · doi:10.1016/j.cell.2019.07.019 · Cited by 541
Hepatocyte Death: A Clear and Present Danger
Malhi, H., Guicciardi, M. E., & Gores, G. J. (2010) · Physiological Reviews · doi:10.1152/physrev.00061.2009 · Cited by 477
Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells
Rehermann, B. (2013) · Nature Medicine · doi:10.1038/nm.3251 · Cited by 468
Self-citationControl of Human Viral Infections by Natural Killer Cells
Jost, S., & Altfeld, M. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100001 · Cited by 458
Immune responses and immunopathology in acute and chronic viral hepatitis
Shin, E.-C., Sung, P. S., & Park, S.-H. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.69 · Cited by 365
Metadata
- Authors
- Ahlenstiel, G., Titerence, R. H., Koh, C., Edlich, B., Feld, J. J., Rotman, Y., Ghany, M. G., Hoofnagle, J. H., Liang, T. J., Heller, T., & Rehermann, B.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2010-01
- Volume
- 138
- Issue
- 1
- Pages
- 325-335.e2
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2031235649
- Cited by
- 270
- References
- 41
- FWCI
- 10.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.